NCT00123227View on ClinicalTrials.gov

Rosiglitazone Plaque Study

PHASE3UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

May 31, 2005

Conditions
Diabetes Mellitus, Type 2Vascular DiseasesHypertension
Interventions
DRUG

Rosiglitazone

Trial Locations (2)

SW3 6NP

Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London

W2 1NY

St Mary's NHS Trust, London

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

CORDA, The Heart Charity

OTHER

lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER

NCT00123227 - Rosiglitazone Plaque Study | Biotech Hunter | Biotech Hunter